Who Paid My Doc
Pataday
Drug Ophthalmology
NDC 0065-0272-25
General payments
$181,687
Research payments
$628,678
Through program year 2025, $181,687 in general payments and $628,678 in research payments were reported against Pataday (Ophthalmology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $38,040 | 13 |
| 2024 | General | $52,649 | 23 |
| 2023 | General | $14,190 | 9 |
| 2022 | General | $28,054 | 13 |
| 2022 | Research | $387,365 | 6 |
| 2021 | General | $48,335 | 41 |
| 2021 | Research | $241,313 | 6 |
| 2020 | General | $420 | 1 |
Breakdown
The top 5 of 13 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 11 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
100 general · 12 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.